Prosecution Insights
Last updated: May 29, 2026

Japan Science And Technology Agency

5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 35 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (40%)
2
Easy (40%)
1
Unknown (20%)

Rejection Statute Mix

BucketCases
§103 only1 (20%)
§102 only1 (20%)
§112 only2 (40%)
No statute on record1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
60% of docket
1
Information Tech
20% of docket
0
Communications
0% of docket
1
Semiconductors
20% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
STOFFA, WYATT A 1 79.9% +22.4%
KUCHARCZK, JED A 1 80.2% +15.6%
STAPON, ANTHONY SCOTT 1
STOICA, ADRIAN 1 68.0% +30.6%
MONTANARI, DAVID A 1 65.1% +49.6%

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18463815 QUANTUM ENTANGLEMENT GENERATOR, QUANTUM ENTANGLEMENT GENERATION METHOD, AND QUANTUM COMPUTER STOFFA, WYATT A 117d overdue
17631622 WORD REPRESENTATION DEVICE OF FINITE TYPE FLOW PATTERN, WORD REPRESENTATION METHOD, PROGRAM, LEARNING METHOD OF STRUCTURE SHAPE, AND STRUCTURE DESIGNING METHOD STOICA, ADRIAN 93d overdue
18548109 SN-38 DERIVATIVE, NANO-PARTICLES CONTAINING SAID DERIVATIVE, MEDICINE, AND METHOD FOR PRODUCING SAID NANO-PARTICLES KUCHARCZK, JED A 2d overdue
16611998 LIVER ORGANOID COMPOSITIONS AND METHODS OF MAKING AND USING SAME MONTANARI, DAVID A 9d

Top Art Units

Art UnitApps
2881 1
1623 1
1656 1
2188 1
1632 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18463815 QUANTUM ENTANGLEMENT GENERATOR, QUANTUM ENTANGLEMENT GENERATION METHOD, AND QUANTUM COMPUTER STOFFA, WYATT A 2881 §112 Non-Final OA 117d overdue Pending Sep 08, 2023
18548109 SN-38 DERIVATIVE, NANO-PARTICLES CONTAINING SAID DERIVATIVE, MEDICINE, AND METHOD FOR PRODUCING SAID NANO-PARTICLES KUCHARCZK, JED A 1623 Other Non-Final OA 2d overdue Pending Aug 28, 2023
17768942 mRNA and Method for Producing Same, Device for Producing Protein, and Method for Producing Protein STAPON, ANTHONY SCOTT 1656 §102 Non-Final OA 9d Pending Mar 08, 2023
17631622 WORD REPRESENTATION DEVICE OF FINITE TYPE FLOW PATTERN, WORD REPRESENTATION METHOD, PROGRAM, LEARNING METHOD OF STRUCTURE SHAPE, AND STRUCTURE DESIGNING METHOD STOICA, ADRIAN 2188 §103 Final Rejection 93d overdue Pending Jan 31, 2022
16611998 LIVER ORGANOID COMPOSITIONS AND METHODS OF MAKING AND USING SAME MONTANARI, DAVID A 1632 §112 Final Rejection 9d Pending Nov 08, 2019

Managing Japan Science And Technology Agency's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month